文献速递主动脉疾病

亚急性与慢性B型主动脉夹层腔内修复的临床与形态学结局

Clinical and Morphologic Outcomes of Endovascular Repair for Subacute and Chronic Type B Aortic Dissection.
PubMed 文献 · Ann Vasc Surg · 2020-09-02

结果显示胸段主动脉重塑良好而腹段不佳,5年生存率77%,但远期主动脉相关死亡仍存在,远端扩张再干预常见。

要点

  • TEVAR对亚急性和慢性TBAD的胸段主动脉重塑良好,腹段重塑不佳。
  • 5年生存率77%,远期仍有主动脉相关死亡。
  • 远端主动脉扩张需再干预常见,强调随访重要性。

核心结论

  • TEVAR治疗亚急性和慢性TBAD可带来良好的胸段主动脉重塑,但腹段主动脉重塑不佳。
  • 5年生存率接近80%,但远期主动脉相关死亡仍会发生。
  • 治疗段远端主动脉扩张需再干预常见,强调随访的重要性。

研究设计与样本

  • 平均年龄62.4岁,DeBakey IIIA型10例(20%),IIIB型40例(80%)。
  • 45例标准TEVAR,2例分支TEVAR,3例TEVAR联合开窗或分支EVAR。

主要发现

  • 3年和5年生存率分别为92%(95%CI [79; 97])和77%(95%CI [61; 87])。
  • 19例晚期死亡中6例确认主动脉相关。
  • 5年免于再干预率为69%(95%CI [53-80]),再干预多因主动脉扩张行远端支架延长。
  • 平均最大主动脉直径术前58.7 mm,末次随访51.9 mm(P = 0.003)。

临床怎么用

  • 对于亚急性或慢性TBAD,TEVAR可考虑用于促进胸段主动脉重塑。
  • 术后需长期影像随访,重点监测远端主动脉扩张及再干预需求。

局限性

  • 随访时间不等,影像随访中位46个月。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The objective of the study was to assess long-term remodeling, survival, and reintervention outcomes after thoracic endovascular aortic repair (TEVAR) for subacute and chronic type B aortic dissection (TBAD). METHODS: All patients who underwent TEVAR for subacute or chronic TBAD at a tertiary referral center between 1999 and 2015 were included in this cohort study. The primary outcome was aortic remodeling, and secondary outcomes included survival, rate of major complications, and reinterventions. RESULTS: Fifty patients were included, with mean age of 62.4 years, 10 (20%) DeBakey type IIIA and 40 (80%) DeBakey type IIIB dissection; 45 standard TEVAR, 2 branched TEVAR, 3 TEVAR combined with fenestrated or branched EVAR. Indication for TEVAR was intact (n = 40) or ruptured (n = 1) postdissection aneurysm, hypoperfusion (n = 4), treatment-refractory pain (n = 2), or a combination (n = 3). Mean clinical follow-up was 76 months, and median radiological follow-up was 46 months. Thirty-day survival was 96%, stroke 4%, renal failure 0%, paraplegia 0%. Three- and five-year survival was 92% (95% confidence interval (CI) [79; 97]) and 77% (95% CI [61; 87]), respectively. Of 19 late deaths, 6 were confirmed aorta related. Five-year freedom from reintervention was 69% (95% CI [53-80]). Distal stent graft extension due to aortic dilatation composed most reinterventions. Mean maximal aortic diameter was 58.7 mm preoperatively and 51.9 mm on last follow-up (P = 0.003). On thoracic level, true lumen expanded (+10.0 mm, 95% CI [6.4; 13.6]) (P < 0.001) and false lumen decreased (-11.9 mm, 95% CI [-15.2; -8.5]) (P < 0.001) from baseline to the last computed tomography. In the abdominal aorta, true lumen diameter change was +3.1 mm (95% CI [1.4; 4.8]) (P = 0.001); false lumen diameter change was +1.0 mm (95% CI [-1.8; 3.8]) (P = 0.464). CONCLUSIONS: TEVAR for subacute and chronic TBAD results in favorable remodeling of the thoracic but not the abdominal aorta. Five-year survival is almost 80%, but late aortic deaths still occur. Aortic dilatation distal to the treated segment requiring reintervention is common, emphasizing the importance of follow-up.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hellgren T, Kuzniar M, Wanhainen A, et al. Clinical and Morphologic Outcomes of Endovascular Repair for Subacute and Chronic Type B Aortic Dissection. Ann Vasc Surg. 2020. PMID: 32889157. doi:10.1016/j.avsg.2020.08.107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。